key: cord-0751063-84gg6lfs authors: Ochoa, Juan B.; Cárdenas, Diana; Goiburu, María E.; Bermúdez, Charles; Carrasco, Fernando; Correia, M. Isabel T. D. title: Lessons learned in Nutrition Therapy in patients with severe COVID‐19 date: 2020-08-24 journal: JPEN J Parenter Enteral Nutr DOI: 10.1002/jpen.2005 sha: b812960dfc87c0e8ce2db0e5a6bd411e8467523a doc_id: 751063 cord_uid: 84gg6lfs The COVID‐19 pandemic has reached worldwide and until a vaccine is found it will continue to cause significant morbidity and mortality. The clinical presentation of COVID‐19 ranges from that of being asymptomatic to developing a fatal illness characterized by multiple organ involvement. Approximately 20% of the patients will require hospitalization; one quarter of hospitalized patients will develop severe COVID‐19 requiring admission to the intensive care unit, most frequently, with acute respiratory failure.An ongoing effort is being made at identifying the patients that will develop severe COVID‐19. Grossly, patients present with three different nutritional risk phenotypes: 1) the frail older patient, 2) the patient with severe ongoing chronic illness, and 3) the patient with severe and morbid obesity. These three phenotypes represent different nutritional risks, and diverse nutrition interventions. This article explores the different potential approaches to nutrition intervention in patients with COVID‐19 evaluating, in this process, the challenges faced for the implementation of guidelines written by different societies. This article is protected by copyright. All rights reserved COVID-19 disease is caused by SARS-CoV-2 virus. First detected as a cause of atypical severe pneumonia in Wuhan, China, at the end of December 2019, SARS-CoV-2 has now become widespread, causing a world pandemic, whose consequences we are only beginning to comprehend. SARS-CoV-2 is a corona virus, which most likely "jumped" species, readily spreading through droplets amongst human beings [1] . The incubation period for COVID-19 is around 2 weeks. Patients will, on average present with clinical manifestations within four to five days. A significant number of patients are asymptomatic, an issue that favors the circulation of the virus amongst populations [2] . One of the most interesting and important observations of the COVID-19 illness is the widespread range of clinical presentations. Approximately 80% will present with a mild disease that can be managed at home, while twenty percent, on the other hand, will require hospitalization, and 25% of those hospitalized (5% of the total population of infected patients) will need to be admitted to the intensive care unit (ICU) [3] [4] [5] . The principal manifestation of patients with severe COVID-19 is respiratory distress and impending respiratory failure. However, other organs/systems are likely to be compromised, including the gastrointestinal tract [4] . Length of stay in the ICU tends to be prolonged and recovery may take a significant amount of time, which is often associated with muscle deconditioning and ICU acquired weakness. Risk factors for the development of severe illness were identified when the disease first appeared in China and have been confirmed in other countries. Metabolic/nutritional issues including obesity, hyperlipidemia, diabetes, and frailty have been identified as significant risk factor for developing severe COVID-19. We propose that patients with severe COVID-19 fall into three distinct, albeit partially overlapping nutritional phenotypes : 1) the frail older patient, 2) the patient with severe ongoing chronic illness, and 3) the patient with severe and morbid obesity. This article expands on the hypothesis that the different phenotypes predict distinct nutritional risks and demand differential approaches towards providing optimal medical nutrition therapy. Published data suggest that older age is the single most important risk factor in determining the severity and mortality risk for COVID-19. This is most likely associated to various comorbidities and polypharmacy. Hypertension and cardiovascular disease, highly prevalent among the older adults, are per se risk factors for worst outcomes [6] . So is diabetes, also commonly found among this group of patients [7] . COVID-19 has mercilessly attacked the old and is particularly virulent in nursing homes [8] . Frailty is a uniquely important characteristic of these group of patients and is associated with malnutrition/sarcopenia. In particular, low protein and micronutrient intake are prevalent in this patient population [9] . On the other hand, due to another world pandemic -obesity -also commonly prevalent in this group of individuals [10] , malnutrition diagnosis is frequently missed [11] . Nutrition assessment in frail older adult patients should thus focus on different clinical variables such as eating habits, non-volitional weight loss and assessment of muscle mass. Both anatomic studies such as evaluation of psoas muscle by CT scan or assessment of quadriceps by ultrasound should be performed. CT-scan assessment is, in general, a convenient method, but under the COVID-19 pandemic, it has been recommended only for symptomatic or hospitalized patients [12] . Dynamic studies to assess muscle strength and endurance should also be done if possible. Debilitating illnesses such as cirrhosis, end stage renal disease, active cancers, and pulmonary diseases are risks for the development of severe COVID-19, as well, as the previous mentioned cardiovascular disease and diabetes. Patients with these diseases commonly present with malnutrition, often also underdiagnosed and untreated. The nutritional status of these patients varies from disease to disease and patient to patient, but classical data have shown prevalence to be as high as 50% [13, 14] . Obesity (BMI >30 kg/m 2 ) is a risk factor of pejorative evolution of COVID-19, increasing the risk of ICU admission, and is independent of age. The CDC identifies severe obesity (defined as a BMI > 40 kg/m 2 ) as prominently associated with the development of severe COVID-19 [15] , being the single most important risk factor in younger patients [16] . Severe obesity is a causative factor for other metabolic diseases including type 2 diabetes mellitus and hyperlipidemia causing target organ damage including coronary artery disease, hypertension, and chronic kidney disease. Patients with COVID-19 who suffer from severe obesity, may also present with decompensated hyperglycemia and elevated lipids, which are also risk factors for the severity of COVID-19 [15, 17] . Simmonet et al. [18] showed that obesity (BMI > 30kg/m 2 ) and severe obesity (BMI >35 kg/m2) were seen in 47.6% and 28.2% of cases, respectively of their ventilated patients. The authors ran a multivariate statistical model which identified severe obesity as an independent risk factor for disease severity and the need for invasive ventilation. Another short communication from a University Hospital of Lyon, France observed a significant higher percentage of ventilated patients in those with BMI > 35 kg/m 2 compared to patients with BMI < 25 kg/m 2 (81.8% versus 41.9%, p=0.001) [19] . The mechanism(s) of why morbid obesity is an independent risk factor for the development of severe Covid-19 remain to be confirmed. One of the potential explanations could be associated with the role of epicardial adipose tissue, inflammation, myocardial fibrosis and reduced angiotensinconverting enzyme 2 (ACE2) expression [19, 20] . In fact, postmortem autopsy heart tissues from 20 individuals who died of COVID-19, showed detectable viral SARS-CoV genome, and reduced myocardial ACE2 expression, increased inflammation and fibrosis [20] . Another possible explanation involves the adipose tissue as an actor for viral systemic spread, with a prolonged viral shedding from a tissue already inflamed. Activation of the immune system in patients with obesity, with dysfunction of macrophages and lymphocytes could amplify viral tissue damage, and the adipose tissue in a state of "pre-activation", with increased production of TNF alpha, IL1 and IL6, could amplify the inflammatory response triggered by SARS CoV 2 infection [22] . Studies in COVID-19 show that IL-6, which is exaggeratedly increased during a cytokine storm, is a strong independent predictor of mortality [23] . Another study conducted in patients undergoing surgical trauma [24] , showed an exaggerated increase in IL-6 both in plasma and in adipose tissue of patients with severe obesity compared to patients with normal weight, a situation that could be reproduced in other conditions that trigger a large inflammatory response, as is the case of COVID-19. Increase morbidity and mortality associated with obesity was also observed in SARS, suggesting a common element in both illnesses [20] . Additionally, increased susceptibility to severe infection has also been observed in rodent models of obesity [21] . Table 1 presents a list of possible, causative hypotheses of why obesity is such a high-risk factor for the development of COVID-19. There are multiple possible hypotheses, which are not necessarily exclusive of each other, that deserve at least a discussion and possibly careful testing. Understanding what the cause of increased susceptibility to severe COVID-19 in patient with severe obesity is may lead to improved mechanisms of prevention and treatment. Furthermore, it will create an increased understanding of the disease of obesity. This article is protected by copyright. All rights reserved. Several professional nutrition organizations have released COVID-19 guidelines [22, 23] . These guidelines are important, and the reader is urged to follow them. Nonetheless, we have found, in our clinical practice with COVID-19 patients however, that there are unique circumstances that alter how these guidelines are applied. We provide below, a perspective. There are several important characteristics of the COVID-19 pandemic that obligate us to alter our approach to these patients, adapting our practices to better serve their needs. The first one is the need for isolation. This limits access to the patients and eventually reduces the participation of professionals who advise on their nutritional care. In addition, the sheer number of patients that can be seen at any given time may overwhelm the limited healthcare resources of a given institution including that of specialized nutrition professionals. We may therefore have to rely on professionals with little experience and, therefore, the nutrition assessment and intervention needs to rely on simplified protocols. Finally, it may be impractical to use sophisticated nutrition assessment tools due to the risk of contamination. Due to the nature of COVID-19, access to the patient for a complete nutrition assessment may be limited. Despite these limitations, the nutrition clinician or any other assistant clinician should try at identifying to which one of the three phenotypes described above the patient may fall into. The nutrition clinician should put emphasis on identifying the presence of malnutrition. Although, the diagnosis of malnutrition may require various tools, it has been shown that clinical assessment tools such as subjective global assessment predicts complications [24] . However, this method demands training and maybe a critical drawback in times of experts' shortage. In cancer populations, unintentional weight loss alone was as good predictor for mortality as sophisticated tools, such as CT scans aimed at assessing muscle mass [25, 26] . Obtaining laboratory samples may be limited in patients with COVID-19 again due to the need for isolation, and potentially due to the need to manage resources carefully if the hospital is seeing a very large number of patients at the same time. Upon arrival however, every effort should be made to obtain key laboratory values. There are two types of laboratory tests that need to be done. The first one involves nonspecific studies, aimed at understanding the severity of illness on presentation, and the second one involves laboratory values that may help in the assessment of the nutritional status (table 2) . Determining the nutritional status of the patients is key as this will help define the need for immediate nutrition therapy (if the patient is metabolically and hemodynamic stable) or a more conservative approach for the well-nourished patients. Indirect calorimetry has emerged as the only consistently reliable tool to assess caloric needs. The European Society of Parenteral and Enteral Nutrition (ESPEN) suggests in their guidelines that indirect calorimetry is a better way of avoiding excessive delivery of nonprotein calories as compared to standard and widely used formulas [22] . Under the best of the circumstances the adoption of indirect calorimetry has been challenging making it practically impossible to apply this technology in the middle of a pandemic [27] . Indirect calorimetry requires training, a stable patient with specific ventilation parameters including a low inspired fraction of oxygen (FI02), and a significant amount of time at the bedside. In addition, the data obtained is difficult to interpret in patients that have significant ventilation perfusion (V/Q) mismatch as is seen frequently during COViD-19 with the potential to generate falsely elevated values [28] . Besides, indirect calorimetry may increase the risk of breaking the ventilatory circuit, generating aerosols and exposing the health care worker to contamination [23] . Patients with severe COVID-19 exhibit impaired oxygenation and carbon dioxide production associated with shunting, V/Q mismatch and potentially increased dead space. Often patients exhibit a high minute ventilation exacerbated by the hypercapnia and hypoxia observed. From the practical point of view, these physiologic problems may render indirect calorimetry inaccurate and difficult to interpret and/or even contraindicated [29, 30] . Protein requirements should be in accordance to the suggested for critically ill-patients which vary from 1.3 to 2.0 g/kg/day, respecting the patients renal and hepatic functions [22] . Micronutrients must also be delivered according to the established requirements for critically ill patients [22] . Initiation of early enteral nutrition, defined as starting nutrition intervention in the first 24 to 48 hours, is suggested in all guidelines. While this is ideal, there are significant barriers in the implementation of early oral intake or enteral nutrition, for COVID-19 patients. Impending acute respiratory failure limits the capacity for patients to eat adequately and/or receive oral nutritional supplements. Also, alterations in olfactory and gustatory senses have been described [31] . Lechien et al. assessed the occurrence of these disorders in patients with confirmed COVID-19, in 12 European hospitals, and 85.6% of the patients reported olfactory dysfunctions, while 88.0% had gustatory alterations, with females being more affected than males [31] . Furthermore, it is frequent to use noninvasive ventilation including masks to deliver positive pressure breathing to these patients. In addition, they may require emergent endotracheal intubation increasing the risk of aspiration during induction if the patient has just eaten. It is often that we observe, particularly in the first 48 hours of the patient being admitted to the ICU, a significant degree of multiple organ system dysfunction and/or failure. These may take significant priority and or impede the implementation of early enteral nutrition. The so-called rescue phase of critical care illness demands that hemodynamic and respiratory parameters take precedence over other organ functions. Many of these patients will require sophisticated ventilatory management and most will require the use of vasopressors due to hemodynamic instability. This again may limit early initiation of enteral nutrition therapy. Early parenteral nutrition initiation is a tempting alternative, considering the aforementioned aspects related to the enteral route. Multiple studies involving thousands of patients now have demonstrated that early parenteral nutrition aimed at avoiding the development of a caloric deficit is of no value and in fact may be associated with significant side effects [32] [33] [34] [35] [36] particularly when the nutrition status of the patients are not considered, an aspect most studies have not addressed. Access to an exclusive intravenous port for the delivery of parenteral nutrition may also be limited. Resources may also be stretched. Therefore, the authors suggest caution at using parenteral nutrition too liberally. Perhaps the most important exception to this may be the patient with an underlying severe protein and calorie malnutrition, for whom early parenteral nutrition has a better chance of benefit and lower risks to the patient. This may be particularly useful in the frail, older patient, or that with chronic underlying conditions. Most patients will remain on a stable dose of vasopressors for several days or even weeks. There are contrasting experiences on the success of achieving nutritional goals using enteral nutrition exclusively in patients with COVID-19. However, the consensus remains that enteral nutrition is the first line of nutritional therapy for patients with severe COVID-19. The suggestion is to start with trickle feeding limiting volumes initially and slowly ramping up to meet nutritional goals by the end of the first week in the ICU. Understanding nutritional goals is important. Multiple studies aimed at eliminating a caloric deficit through nutrition intervention in the first week in the ICU demonstrate no observable benefit and significant side effects [32] . Therefore, the goals should be different. Protein intake should be "ramped up" in the first few days in the ICU and should be aimed at achieving, at least, 1.3 g/kg/day of current body weight for non-overweight patients and ideal body weight for the overweight by the end of the first week [37] . Controversy exists as to how much higher protein intake should be delivered and no recommendation can be given at this time, regarding the COVID-19 patients. Micronutrient deficiencies ideally identified early on should also be treated. Guidelines suggest, that at least during the first week in the ICU, patient should receive limited amount of nonprotein calories. In the absence of indirect colorimetry (which occurs in most patients) clinicians should attempt to achieve 50 to 70% of caloric goals in the first week, considering the estimation based on the quick formula of 25 kcal/kg/day or less than 20 kcal/kg of ideal weight (<70% of calculated energy needs) for the overweight patient [38, 39] . Most enteral nutritional formulas are designed to achieve a protein to calorie ratio of 150:1. There is a clear risk of delivering excessive calories if the clinician aims at achieving the protein target suggested. The use of supplemental protein modules has been suggested in the literature. However, these are cumbersome to implement, and in patients with COVID-19 with limited access, they may be impractical. Recently, very high protein (VHP) formulas with lower nonprotein caloric concentrations have been designed and commercialized by different companies. These formulas contain 35-37% protein concentrations. Some of these formulas limit the amounts of lipids while others limit the amount of carbohydrates delivered. A phase 2 trial using one of these formulas demonstrated that protein goals could be easily achieved with lower volumes, avoiding the excess and caloric delivery. In this study, significant biochemical benefits including an improvement in glucose control, and a potential decrease in CO 2 production was observed [39] . These formulas appear to be beneficial, and further research is badly needed to determine whether there is an advantage towards using VHP formulas compared to standard of care in COVID-19. Average length of stay in the ICU is often limited to less than 7 days in non COVID patients. By seven days, the inflammatory response associated with illness that prompted transfer of the patient to the ICU may have subsided. There is a paucity of data associated with what nutritional goals should be achieved for those patients that stay longer than seven days in the ICU. Despite the lack of adequate data, recommendations suggest that liberalizing delivery of calories to achieve 100% of the calculated goals is indicated [22] . However, there are two issues that prompt us to be cautious of delivering 100% of the caloric goals in patients with COVID-19. The first one is that patients with severe COVID-19 often continue to exhibit an ongoing inflammatory response during the second week and even thereafter for several weeks. The second one is the fact that many patients, particularly the young, have associated severe or morbid obesity. This cannot be ignored as we design and implement nutritional intervention for these patients. Furthermore, many of these patients continue to have significant metabolic derangements including stress hyperglycemia and hyperlipidemia (hypertriglyceridemia). Meeting caloric goals only contributes to worsen these problems. All these issues prompt us to continue to be cautious at delivering 100% of the caloric goals. The exception to this rule continues to be the patient with severe malnutrition and exhaustion of any caloric reserves. Little is known as to the best way to provide medical nutrition therapy to any patient that has survived critical illness. There is enormous variation in how fast and to what degree patients recover. Despite the best attempt by clinicians, all patients lose muscle mass and are in negative nitrogen balance during their ICU stay. Muscle weakness is universal and is particularly marked in patients with prolonged ICU stay [40] . Some key opinion leaders suggest that providing increased protein and calories is indicated for all patients during the recovery phase, aiming to achieve a restoration of muscle mass. This is certainly the case for the patient that can participate in active rehabilitation. The application of a resistance exercise training program could be a strategy from early stages of the rehabilitation of patients after the critical condition although the evidence for benefits is insufficient [41] . However, there are risks of advocating for the use of high caloric intake to all. These include: 1-The patient with limited mobility and lower energy expenditures. In these patients providing increased energy intake will tax metabolic systems and increase cardiopulmonary demands. 2-The patient with severe or morbid obesity, particularly those with continued metabolic diseases including diabetes. There is a chance to address obesity in patients that are recovering after critical illness. In these patients, continued use of nutritional programs including supervised lower caloric higher protein intake may achieve the best results. The COVID-19 pandemic has taxed intensive care units worldwide. Severe COVID-19 is a complex disease, which we are only beginning to understand. Nutrition societies have used generic guidelines to suggest how the nutritional needs of patients should be addressed. Our article expands beyond this to suggest practical applications, utilizing lessons that we have learned at the bedside. This article is protected by copyright. All rights reserved. Complete white blood cell count and differential -identify the presence of lymphopenia Coagulation status laboratory values including platelet count D dimer -to assess the presence of coagulopathy C-reactive protein, procalcitonin, to assess the severity of inflammatory response Vitamin D -identify the presence of vitamin D deficiency and begin treatment Albumin. Not specific for malnutrition but it negatively correlates with inflammation Presence of micro or macrocytic anemia -aimed at identifying iron and B vitamin deficiencies Caution -iron levels will be low and ferritin levels will be high in patients with severe inflammatory response and should not prompt iron replacement. 2019-nCoV in context: lessons learned? The Lancet. Planetary health Covid-19: risk factors for severe disease and death COVID-19) -United States Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the Severe Covid-19 COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options COVID-19 pandemic, coronaviruses, and diabetes mellitus Epidemiology of Covid-19 in a Long-Term Care Facility in King County Dietary Protein, Exercise, and Frailty Domains Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator A requiem for BMI in the clinical setting COVID-19-New Insights on a Rapidly Changing Epidemic Hospital malnutrition: the Brazilian national survey (IBRANUTRI): a study of 4000 patients Hospital malnutrition in Latin America: A systematic review Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms Targeting the Adipose Tissue in COVID-19 Diabetes is a risk factor for the progression and prognosis of COVID-19 High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2 Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Frontiers in cardiovascular medicine ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive care medicine Subjective global assessment: a reliable nutritional assessment tool to predict outcomes in critically ill patients Different nutritional assessment tools as predictors of postoperative complications in patients undergoing colorectal cancer resection Nutritional Status Parameters as Risk Factors for Mortality in Cancer Patients Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand COVID-19: a hypothesis regarding the ventilation-perfusion mismatch Nutrition Therapy in Critically Ill Patients with Coronavirus Disease (COVID-19) Hypermetabolism and COVID-19 Olfactory and gustatory dysfunctions as a clinical presentation of mild-tomoderate forms of the coronavirus disease (COVID-19): a multicenter European study Early versus late parenteral nutrition in critically ill adults Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trial The Benefits of Parenteral Nutrition (PN) Versus Enteral Nutrition (EN) Among Adult Critically Ill Patients: What is the Evidence? A Literature Review Enteral vs. parenteral nutrition in septic shock: are they equivalent? Resting energy expenditure, calorie and protein consumption in critically ill patients: a retrospective cohort study ESPEN guideline on clinical nutrition in the intensive care unit Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition Exploration of muscle loss and metabolic state during prolonged critical illness: Implications for intervention? PloS one